Neurocrine Biosciences
NBIX
#1454
Rank
NZ$25.27 B
Marketcap
NZ$253.47
Share price
1.74%
Change (1 day)
4.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company